How semaglutide, tirzepatide, and retatrutide are studied as single, dual, and triple receptor agonists.
GLP-1 receptor agonists are a widely studied class in metabolic research. Semaglutide acts on the GLP-1 receptor; tirzepatide is a dual GLP-1/GIP agonist; retatrutide adds glucagon-receptor activity as a triple agonist.
Comparing single, dual, and triple mechanisms is an active area of laboratory study into metabolic signalling pathways.
This is general educational background for research use only, not medical or usage guidance.
All products are sold strictly for laboratory and research use only. They are not for human or veterinary consumption, and no medical, dosing, or usage guidance is provided. By ordering you confirm you are 18+ and acquiring these materials for legitimate research purposes.